Beam Therapeutics (BEAM)
(Delayed Data from NSDQ)
$18.83 USD
-0.88 (-4.46%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $18.82 -0.01 (-0.05%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Beam Therapeutics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BEAM 18.83 -0.88(-4.46%)
Will BEAM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BEAM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BEAM
Vir Biotechnology, Inc. (VIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
3 Genomics Stocks Worth Adding to Your Portfolio in 2025
BEAM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Beam Therapeutics Inc. (BEAM) Report Negative Q2 Earnings? What You Should Know
Innovation ETF (ARKK) Hits New 52-Week High
3 Promising Genomics Stocks to Keep an Eye On in 2025
Other News for BEAM
Cathie Wood Starts This Volatile Week with $13M Buy and a Key Sell-Off
Cathie Wood's ARK Investment buys 659K shares of Beam Therapeutics today
Cathie Wood's ARK Investment buys 29K shares of Beam Therapeutics today
Cathie Wood's ARK Investment buys 55K shares of Beam Therapeutics today
Cathie Wood's Ark Invest Continues To Offload Coinbase, Bets Big On SoFi Technologies